Cardiac events in patients with HER2-positive metastatic breast cancer who have low left ventricular ejection fraction prior to initiating treatment with ado-trastuzumab emtansine: A retrospective cohort study using electronic health record data

Category Primary study
JournalCancer Research
Year 2020
This article has no abstract
Epistemonikos ID: 33431a0b8115f4c859b259aacf4c6eb3c8c66f53
First added on: Feb 11, 2025